Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 153.27
-0.013 %
$ 15.5 B
Market Cap
40.87
P/E
NBIX - TOTAL ASSETS
Total Assets NBIX - Neurocrine Biosciences, Inc.
3.25 B
LAST VALUE
25.25%
2 YEAR CAGR
26.77%
5 YEAR CAGR
35.60%
10 YEAR CAGR